Role of an ATP-sensitive potassium channel opener, YM934, in mitochondrial energy production in ischemic/reperfused heart

Journal of Pharmacology and Experimental Therapeutics

Volumn 291, Issue 2, 1999, Pages 710-716

  Tanonaka, Kouichi ^a   Taguchi, Taku ^a   Koshimizu, Miki ^a   Ando, Tsuyoshi ^a   Morinaka, Tomohiro ^a   Yogo, Tomoya ^a   Konishi, Fusako ^a   Takeo, Satoshi ^a  

^a TOKYO UNIVERSITY OF PHARMACY AND LIFE SCIENCES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

2 (3,4 DIHYDRO 2,2 DIMETHYL 6 NITRO 2H 1,4 BENZOXAZIN 4 YL)PYRIDINE 1 OXIDE; 5 HYDROXYDECANOIC ACID; ADENOSINE TRIPHOSPHATE; CREATINE KINASE; CREATINE PHOSPHATE; GLIBENCLAMIDE; OXYGEN; POTASSIUM CHANNEL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ENERGY METABOLISM; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART VENTRICLE ENDDIASTOLIC PRESSURE; HYPOXIA; MALE; MITOCHONDRION; NONHUMAN; OXYGEN CONSUMPTION; PRIORITY JOURNAL; RAT;

ADENOSINE TRIPHOSPHATE; ANIMALS; ANOXIA; ANTI-ARRHYTHMIA AGENTS; CREATINE KINASE; CYCLIC N-OXIDES; DECANOIC ACIDS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; GLYBURIDE; HEART VENTRICLES; HEMODYNAMIC PROCESSES; HYDROXY ACIDS; MALE; MITOCHONDRIA, HEART; OXAZINES; OXYGEN CONSUMPTION; PERFUSION; PHOSPHOCREATINE; RATS; RATS, WISTAR; REPERFUSION INJURY; TIME FACTORS;

EID: 0032745269     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Bergmeyer HU, Rich W, Buther H, Schmidt E, Hillman G, Kreu FH, Stamm D, Lang H, Szasz G and Laue D (1970) Standardization of methods for estimation of enzyme activity in biological fluids. Z Kiln Chem Biochem 8:658-669.
2. Challinor-Rogers JL and McPherson GA (1994) Potassium channel openers and other regulators of KATP channels. Clin Exp Pharmacol Physiol 21:583-597.
3. + channels: Possible mechanism of cardioprotection. Circ Res 81:1072-1082.
4. ATP channel as a receptor for potassium channel openers. J Biol Chem 271:8796-8799.
5. Gross GJ (1995) ATP-sensitive potassium channels and myocardial preconditioning. Basic Res Cordiol 90:85-88.
6. Grover GJ (1994) Protective effects of ATP-sensitive potassium channel openers in experimental myocardial ischemia. J Cardiovasc Pharmacol 24 (Suppl):S18-S27.
7. ATP) openers in models of myocardial ischemia and reperfusion. Can J Physiol Pharmacol 75:309-315.
8. Grover GJ, D'Alonzo AJ, Hess T, Sleph PG and Darbenzio RB (1995b) Glyburide-reversible cardioprotective effect of BMS-180448 is independent of action potential shortening. Cardiovasc Res 30:731-738.
9. ATP opener cromakalim is not correlated with ischemic myocardial action potential duration. J Cardiovasc Pharmacol 26:145-152.
10. Grover GJ, McCullough JR, Henry DE, Conder ML and Sleph PG (1989) Anti-ischemic effect of the potassium channel activators pinacidil and cromakalim and the reversal of these effects with the potassium channel blocker glyburide. J Pharmacol Exp Ther 251:98-104.
11. Hearse DJ (1995) Activation of ATP-sensitive potassium channels: A novel pharmacological approach to myocardial protection. Cardiovasc Res 30:1-17.
12. + channels modulate cardiac function. Am J Physiol 275:H1567-H1576.
13. + channel in the mitochondrial inner membrane. Nature (Lond) 352:244-247.
14. + channel summits confer resistance to chemical hypoxia-reoxygenation injury. Circulation 98:1548-1555.
15. Katz AM (1977) Energetics of muscle, in Physiology of Heart (AM Katz ed) pp 25-34, Raven Press, New York.
16. ATP channel. Am J Physiol 271:H1769-H1777.
17. ATP channel. Am J Physiol 273:H847-H853.
18. Liu Y, Gao WD, O'Rourke B and Marban E (1996) Cell-type specificity of preconditioning in an in vitro model. Basic Res Cordial 91:450-457.
19. Liu Y, Sato T, O'Rourke B and Marban E (1998) Mitochondrial ATP-dependent potassium channels: Novel effectors of cardioprotection? Circulation 97:2463-2469.
20. + channel. Mol Cell Biol 18:1652-1659.
21. Lowry OH and Passonneau JR (1972) A collection of metabolite assays, in A Flexible System of Enzymatic Analysis (Lowry OH and Passonneau JR eds) pp 120-152, Academic Press, New York.
22. Lowry OH, Rosebrough NJ, Farr AL and Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 261:6300-6306.
23. McCullough JR, Normandin DE, Conder ML, Sleph PG, Dzwonczyk S and Grover GJ (1991) Specific block of the anti-ischemic actions of cromakalim by sodium 5-hydroxydecanoate. Circ Res 69:949-958.
24. + channels involves high-energy phosphate preservation. Am J Physiol 265:H1809-H1818.
25. Nayler WG, Ferrari R and Williams A (1980) Protective effect of pretreatment with verapamil, nifedipine and propranolol on mitochondrial function in the ischemic and reperfused myocardium. Am J Cardiol 46:242-248.
26. 2+ antagonist drugs on the hypoxia induced increase in resting tension. Cardiovasc Res 12:666-674.
27. + channel by 5-hydroxydecanoate in guinea pig ventricular myocytes. J Pharmacol Exp Ther 260:702-708.
28. + channels from rat liver and beef mitochondria. J Biol Chem 267: 26062-26096.
29. Saks VA, Kapelko VI, Kupriyanov W, Kuzneteov AV, Lakomkin VI, Sharov VG, Javadov SA, Seppet EK and Kairane C (1989) Quantitative evaluation of relationship between cardiac energy metabolism and post-ischemic recovery of contractile function. J Mol Cell Cardiol 21 (Suppl 1):67-78.
30. Sanbe A, Tanonaka K, Hanaoka Y, Katoh T and Takeo S (1993) Regional energy metabolism of failing hearts following myocardial infarction. J Mol Cell Cardiol 25:995-1013.
31. Schwarz ER, Whyte WS and Kloner RA (1997) Ischemic preconditioning. Curr Opin Cardiol 12:475-481.
32. Szewczyk A, Wojcik G and Nalecz MJ (1995) Potassium channel opener, RP66471, induces membrane depolarization of rat liver mitochondria. Biochem Biophys Res Commun 207:126-132.
33. Taguchi T, Uchida W, Takenaka T and Takeo S (1999) Cardioprotective effects of YM934, an ATP-sensitive potassium channel opener, on stunned anesthetized dogs. Gen Pharmacol 32:695-703.
34. Takeo S, Miyake K, Tanonaka K, Takagi N, Takagi K, Kishimoto K, Suzuki M, Katsuragi A and Goto M (1996) Beneficial effect of nebracetam on energy metabolism after microsphere-induced embolism in rat brain. Arch Int Pharmacodyn 331:232-245.
35. Takeo S, Tanonaka K, Miyake K and Fukumoto T (1988) Role of ATP metabolites in induction of incomplete recovery of cardiac contractile force after hypoxia. Can J Cardiol 4:193-200.
36. Uchida W, Masuda N, Taguchi T, Shibasaki K, Shirai Y, Asano M, Matsumoto Y, Tsuzuki R, Fujikura T and Takenaka T (1994) Pharmacologic profiles of YM934, a novel potassium channel opener. J Cardiovasc Pharmacol 23:180-187.
37. + channels in cardiac myocytes. J Pharmacol Exp Ther 267:1544-1549.
38. ATP channel opener bimakalim on coronary blood flow, monophasic action potential duration, and infarct size in dogs. Circulation 89:1769-1775.
39. ATP channel face the cytosol. Biochim Biophys Acta 1321:128-136.